![William Demers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Demers
Finanzdirektor/CFO bei
POINT Biopharma, Inc. (United States)
Profil
William Demers is currently the Chief Financial Officer at POINT Biopharma, Inc. in the United States.
Prior to this, he was the Chief Financial Officer at Contract Pharmaceuticals Ltd. and AgMedica Bioscience, Inc. He also worked as a Senior Assurance Partner at Ernst & Young LLP from 2014 to 2018.
In terms of education, he received an undergraduate degree from Wilfrid Laurier University.
Additionally, he is currently serving as the Chief Financial Officer & Secretary at POINT Biopharma Global, Inc. from 2021 to 2023.
Aktive Positionen von William Demers
| Unternehmen | Position | Beginn |
|---|---|---|
POINT Biopharma, Inc. (United States)
 POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Develops next-generation radioligand therapies for the treatment of cancer | Finanzdirektor/CFO | 01.08.2020 |
Ehemalige bekannte Positionen von William Demers
| Unternehmen | Position | Ende |
|---|---|---|
| POIT BIOP | Finanzdirektor/CFO | 27.12.2023 |
AgMedica Bioscience, Inc.
 AgMedica Bioscience, Inc. Chemicals: Major DiversifiedProcess Industries Produces and exports medical cannabis products | Finanzdirektor/CFO | 01.08.2020 |
Contract Pharmaceuticals Ltd.
 Contract Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and packages non-sterile liquid & semi-solid dosage forms | Finanzdirektor/CFO | 01.07.2019 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | 01.06.2018 |
Ausbildung von William Demers
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
70
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Contract Pharmaceuticals Ltd.
Contract Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and packages non-sterile liquid & semi-solid dosage forms | Health Technology |
Wilfrid Laurier University
 Wilfrid Laurier University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AgMedica Bioscience, Inc.
AgMedica Bioscience, Inc. Chemicals: Major DiversifiedProcess Industries Produces and exports medical cannabis products | Process Industries |
POINT Biopharma Global, Inc.
 POINT Biopharma Global, Inc. BiotechnologyHealth Technology Develops radioligand therapies for the treatment of cancer | Health Technology |
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Develops next-generation radioligand therapies for the treatment of cancer | Commercial Services |
